INHIBIKASE THERAPEUTICS, INC.

Transcripts Inhibikase Therapeutics, Inc.

Equities

IKT

US45719W2052

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-20 EDT			5-day change	1st Jan Change
1.86 ^USD	+7.51%		+36.76%	+46.46%

05-16	Transcript : Inhibikase Therapeutics, Inc., Q1 2024 Earnings Call, May 16, 2024
05-09	Inhibikase Therapeutics Announces Final Pre-Ind Meeting Outcomes for Ikt-001Pro as A Treatment for Pulmonary Arterial Hypertension	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Inhibikase Therapeutics, Inc., Q1 2024 Earnings Call, May 16, 2024	05-16
Transcript : Inhibikase Therapeutics, Inc., 2023 Earnings Call, Mar 28, 2024	03-28
Transcript : Inhibikase Therapeutics, Inc., Q3 2023 Earnings Call, Nov 15, 2023	11-15
Transcript : Inhibikase Therapeutics, Inc., Q2 2023 Earnings Call, Aug 15, 2023	23-08-15
Transcript : Inhibikase Therapeutics, Inc., Q1 2023 Earnings Call, May 16, 2023	23-05-16
Transcript : Inhibikase Therapeutics, Inc., Q4 2022 Earnings Call, Apr 03, 2023	23-04-03
Transcript : Inhibikase Therapeutics, Inc. - Special Call	23-03-22
Transcript : Inhibikase Therapeutics, Inc., Q3 2022 Earnings Call, Nov 15, 2022	22-11-15

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW